Abstract
There is a wide spectrum of conditions that affect the pericardium, including congenital defects and cysts, infectious, immune-mediated, metabolic, traumatic, neoplastic and drug-related causes [1] (Table 2.1). Most of these disorders result from an extrapericardial process (e.g., viral infections, uremia, chest radiation therapy), whereas a minority are isolated to the pericardium itself (e.g., cysts). Pathologically, the two most common disease processes are pericarditis (i.e., inflammation) and pericardial effusion. A less frequent development is pericardial constriction, a consequence of inflammatory insults that results in thickening, fibrosis and calcification [2]. Clinically, the presentation of pericardial disease is primarily determined by the degree and chronicity of the inflammatory process, the rate and amount of effusion accumulation, and the degree of any pericardial thickening and fibrosis. The etiology of most cases of acute pericarditis is deemed “idiopathic” as no specific diagnosis is actively sought [3, 4]. The majority of such episodes are believed to be of viral origin.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Blanchard DG, Hagenhoff C, Chow LC, McCann HA, Dittrich HC. Reversibility of cardiac abnormalities in human immunodeficiency virus (hiv)-infected individuals: a serial echocardiographic study. J Am Coll Cardiol. 1991;17:1270–6.
Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J. 1999;137:516–21.
Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, Cheitlin MD. Pericardial effusion in aids. Incidence and survival. Circulation. 1995;92:3229–34.
Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, Soler-Soler J. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol. 1993;22:1661–5.
Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med. 1977;63:666–73.
Augustin P, Desmard M, Mordant P, Lasocki S, Maury JM, Heming N, Montravers P. Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis. Crit Care. 2011;15:220.
Hsu RB, Lin FY. Risk factors for bacteraemia and endovascular infection due to non-typhoid salmonella: a reappraisal. QJM. 2005;98:821–7.
Defouilloy C, Meyer G, Slama M, Galy C, Verhaeghe P, Touati G, Ossart M. Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med. 1997;23:117–8.
Fowler NO. Tuberculous pericarditis. JAMA. 1991;266:99–103.
Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112:3608–16.
Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH. Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the european society of cardiology. Eur Heart J. 2004;25:587–610.
Reuter H, Burgess L, van Vuuren W, Doubell A. Diagnosing tuberculous pericarditis. QJM. 2006;99:827–39.
Ntsekhe M, Wiysonge C, Volmink JA, Commerford PJ, Mayosi BM. Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. QJM. 2003;96:593–9.
Kraus WE, Valenstein PN, Corey GR. Purulent pericarditis caused by candida: report of three cases and identification of high-risk populations as an aid to early diagnosis. Rev Infect Dis. 1988;10:34–41.
Wheat J. Histoplasmosis. Experience during outbreaks in indianapolis and review of the literature. Medicine (Baltimore). 1997;76:339–54.
Hidron A, Vogenthaler N, Santos-Preciado JI, Rodriguez-Morales AJ, Franco-Paredes C, Rassi Jr A. Cardiac involvement with parasitic infections. Clin Microbiol Rev. 2010;23:324–49.
Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum. 1987;17:126–41.
Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y. Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford). 2006;45 Suppl 4:iv8–13.
Grossman LA, Kaplan HJ, Ownby FD, Grossman M. Acute pericarditis with subsequent clinical rheumatoid arthritis. Arch Intern Med. 1962;109:665–72.
Byers RJ, Marshall DA, Freemont AJ. Pericardial involvement in systemic sclerosis. Ann Rheum Dis. 1997;56:393–4.
Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011;97:1882–92.
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–55.
Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M, Brizi MG, Brucato A. Autoinflammatory diseases and cardiovascular manifestations. Ann Med. 2011;43:341–6.
Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci. 2009;338:211–6.
Imazio M, Hoit BD. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013;168:648–52.
Hammerman H, Alker KJ, Schoen FJ, Kloner RA. Morphologic and functional effects of piroxicam on myocardial scar formation after coronary occlusion in dogs. Am J Cardiol. 1984;53:604–7.
Fenstad ER, Le RJ, Sinak LJ, Maradit-Kremers H, Ammash NM, Ayalew AM, Villarraga HR, Oh JK, Frantz RP, McCully RB, McGoon MD, Kane GC. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis and role of drainage. Chest. 2013;144:1530–8.
Hinderliter AL, Willis PWT, Long W, Clarke WR, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Biosblanc B, Koch G, Li S, Clayton LM, Jobsis MM, Crow JW. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. Pph study group. Primary pulmonary hypertension. Am J Cardiol. 1999;84:481–4, A410.
Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Schwartz T, Koch G, Clayton LM, Jobsis MM, Crow JW, Long W. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39:1214–9.
Khan AH. The postcardiac injury syndromes. Clin Cardiol. 1992;15:67–72.
Imazio M, Brucato A, Rovere ME, Gandino A, Cemin R, Ferrua S, Maestroni S, Barosi A, Simon C, Ferrazzi P, Belli R, Trinchero R, Spodick D, Adler Y. Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. Am J Cardiol. 2011;108:1183–7.
Imazio M, Trinchero R, Brucato A, Rovere ME, Gandino A, Cemin R, Ferrua S, Maestroni S, Zingarelli E, Barosi A, Simon C, Sansone F, Patrini D, Vitali E, Ferrazzi P, Spodick DH, Adler Y. Colchicine for the prevention of the post-pericardiotomy syndrome (copps): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749–54.
Holmes Jr DR, Nishimura R, Fountain R, Turi ZG. Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv. 2009;2:705–17.
Erbel R, Engberding R, Daniel W, Roelandt J, Visser C, Rennollet H. Echocardiography in diagnosis of aortic dissection. Lancet. 1989;1:457–61.
Hayashi T, Tsukube T, Yamashita T, Haraguchi T, Matsukawa R, Kozawa S, Ogawa K, Okita Y. Impact of controlled pericardial drainage on critical cardiac tamponade with acute type a aortic dissection. Circulation. 2012;126:S97–101.
Nilsson A, Rasmuson T. Primary pericardial mesothelioma: report of a patient and literature review. Case Rep Oncol. 2009;2:125–32.
Thurber DL, Edwards JE, Achor RW. Secondary malignant tumors of the pericardium. Circulation. 1962;26:228–41.
Chiles C, Woodard PK, Gutierrez FR, Link KM. Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics. 2001;21:439–49.
Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J. Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J. 2014;35:612–23.
Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol. 2001;21:52–6.
Alpert MA, Ravenscraft MD. Pericardial involvement in end-stage renal disease. Am J Med Sci. 2003;325:228–36.
Sever MS, Steinmuller DR, Hayes JM, Streem SB, Novick AC. Pericarditis following renal transplantation. Transplantation. 1991;51:1229–32.
Abbas AE, Appleton CP, Liu PT, Sweeney JP. Congenital absence of the pericardium: case presentation and review of literature. Int J Cardiol. 2005;98:21–5.
Nasser WK. Congenital absence of the left pericardium. Am J Cardiol. 1970;26:466–70.
Cuccuini M, Lisi F, Consoli A, Mancini S, Bellino V, Galanti G, Capaccioli L. Congenital defects of pericardium: case reports and review of literature. Ital J Anat Embryol. 2013;118:136–50.
Gatzoulis MA, Munk MD, Merchant N, Van Arsdell GS, McCrindle BW, Webb GD. Isolated congenital absence of the pericardium: clinical presentation, diagnosis, and management. Ann Thorac Surg. 2000;69:1209–15.
Satur CM, Hsin MK, Dussek JE. Giant pericardial cysts. Ann Thorac Surg. 1996;61:208–10.
Hynes JK, Tajik AJ, Osborn MJ, Orszulak TA, Seward JB. Two-dimensional echocardiographic diagnosis of pericardial cyst. Mayo Clin Proc. 1983;58:60–3.
Maksimovic R, Dill T, Seferovic PM, Ristic AD, Alter P, Simeunovic DS, Markovic Z, Bachmann GF, Maisch B. Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz. 2006;31:708–14.
Kerber RE, Sherman B. Echocardiographic evaluation of pericardial effusion in myxedema. Incidence and biochemical and clinical correlations. Circulation. 1975;52:823–7.
Kabadi UM, Kumar SP. Pericardial effusion in primary hypothyroidism. Am Heart J. 1990;120:1393–5.
Brawley RK, Vasko JS, Morrow AG. Cholesterol pericarditis. Considerations of its pathogenesis and treatment. Am J Med. 1966;41:235–48.
Barcin C, Yalcinkaya E, Kabul HK. Cholesterol pericarditis associated with rheumatoid arthritis: a rare cause of pericardial effusion. Int J Cardiol. 2013;166:e56–8.
Yokusoglu M, Savasoz BS, Baysan O, Erinc K, Gunay C, Isik E. Primary chylopericardium. Thorac Cardiovasc Surg. 2005;53:386–8.
Chan BB, Murphy MC, Rodgers BM. Management of chylopericardium. J Pediatr Surg. 1990;25:1185–9.
Imazio M, Brucato A, Rampello S, Armellino F, Trinchero R, Spodick DH, Adler Y. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown). 2010;11:557–62.
Acknowledgement
We appreciate the dedicated help and suggestions of Dr. Michael J. Landzberg, medical director of the Boston adult congenital heart group, Boston Children’s Hospital and Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Halpern, D.G., Agarwal, V., Lilly, L.S. (2014). Etiologies of Pericardial Diseases. In: Herzog, E. (eds) Management of Pericardial Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-06124-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-06124-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06123-8
Online ISBN: 978-3-319-06124-5
eBook Packages: MedicineMedicine (R0)